1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine
    Journal Article

    Martin, L. P.; Konner, J. A.; Moore, K. N.; Seward, S. M.; Matulonis, U. A.; Perez, R. P.; Su, Y.; Berkenblit, A.; Ruiz-Soto, R.; Birrer, M. J.
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • Tolerance and toxicity of the PARP inhibitor olaparib in older women with ovarian cancer
    Meeting Abstract

    Dockery, L.; Tew, W.; Moore, K.; Ding, K.
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Makker, V.; Rasco, D.; Taylor, M.; Dutcus, C.; Shumaker, R.; Schmidt, E. V.; Stepan, D.; Li, D.; Motzer, R. J.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • ARIEL3: A phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC)
    Meeting Abstract

    Ledermann, J.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J.; Clamp, A.; Scambia, G.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA)
    Meeting Abstract

    Berman, B.; Konner, J.; Belum, V. R.; Dion, H.; Ciccolini, K.; Kitts, S.; Ye, R.; Ravipaty, S.; Akmaev, V. R.; Sarangarajan, R.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Difficult choices in stage I uterine leiomyosarcoma - It's okay to “stand there”
    Journal Article

    Hensley, M. L.
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • Oncologist use and perception of large panel next-generation tumor sequencing
    Journal Article

    Schram, A. M.; Reales, D.; Galle, J.; Cambria, R.; Durany, R.; Feldman, D.; Sherman, E.; Rosenberg, J.; D'Andrea, G.; Baxi, S.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Indications for and complications of transfusion and the management of gynecologic malignancies
    Journal Article

    Cybulska, P.; Goss, C.; Tew, W. P.; Parameswaran, R.; Sonoda, Y.
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology
    Journal Article

    Chiang, S.; Lee, C. H.; Stewart, C. J. R.; Oliva, E.; Hoang, L. N.; Ali, R. H.; Hensley, M. L.; Arias-Stella, J. A. 3rd; Frosina, D.; Jungbluth, A. A.; more...
    Modern Pathology (2017)

    Fulltext@MSK | Save